Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
About this study
The goal of this clinical trial is to learn about the application of domestic PET/MR in major brain diseases. The main questions it aims to answer are: * Overcome the bottleneck of early accurate diagnosis and treatment in major brain diseases clinical practice. * Promote the clinical application of domestic PET/MR, enhance international competitiveness. Participants will have a PET/MR scan of the brain.
- Condition
- Alzheimer Disease, Parkinson Disease, Epilepsy, Malignant Brain Tumor
- Tested
- PET/MR
- Sponsor
- Xuanwu Hospital, Beijing
Who can join
- Age
- 18 to 60 years
- Sex
- All sexes
- Healthy volunteers
- Accepted
Inclusion 5
- Minimum age: 18 years
- Maximum age: 60 years
- Study condition: Alzheimer Disease, Parkinson Disease, Epilepsy, Malignant Brain Tumor
- Patients diagnosed with mild cognitive impairment (MCI) or Alzheimer's disease (AD), rapid eye movement sleep behavior disorder (RBD) or Parkinson's disease (PD), epilepsy, malignant brain tumors based on clinical guidelines.
- Patients admitted to our hospital for inpatient treatment.
Exclusion 5
- Patients who have undergone non-invasive/minimally invasive treatments such as radiotherapy or chemotherapy within the past three weeks. And Patients who have taken Alzheimer's disease-related and Parkinson's disease-related treatment drugs within the past month.
- Patients with persistent seizures or status epilepticus that cannot be controlled by medication, resulting in an inability to cooperate with the examination.
- patients with poorly controlled blood sugar and ineffective medication intervention.
- Patients with absolute contraindications for PET/MR examination.
- Karnofsky Performance Score (KPS) \<60.
Where
1 site, 1 recruiting
Xuanwu hospital
Beijing, Beijing Municipality, China
Contact
-
Jie Lu, Phd
+86 13309824318 imaginglu@hotmail.com
Potential match only. Final eligibility is determined by the study team.